In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...
Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...
Investor's Business Daily on MSN2d
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly ReviewThe stock market surged to highs on Donald Trump's election win. A Fed rate cut and a slew of big earnings reports filled out ...
The fact that semaglutide does not produce hypoglycemia, unlike insulin does make it suitable for obesity management ... the ...
With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to ...
Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer ...
The pharmaceutical company Viking has recently become one of the most volatile stocks on Wall Street due to the announcement ...
Fish oil pills slash the risk of a heart attack or stroke among patients at high risk, according to research. Scientists ...
The Danish company’s share price rise of 7 per cent this year lags far behind its rival Eli Lilly’s 36 per cent, as the US company has gradually increased its share of the obesity and diabetes market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback